Erectile dysfunction (ED) has been the most neglected complication of diabetes. It is a common abnormality that affects more than 20 million American men. The prevalence of ED in the general population between the ages of 40 to 70 years is 52%. In men with diabetes, it ranges from 35% to 75%, and occurs at an earlier age. There have been several advances in the understanding of the physiologic and biochemical mechanisms controlling penile erections. Improved techniques in diagnoses and treatment of impotence have given the male with diabetes some hope in the management of this prevalent and emotionally disturbing complication.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 4.NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence [no authors listed]. JAMA 1993, 270:83–90.Google Scholar
- 7.Spark RF: Overview of male sexual dysfunction. In Up-To-Date, vol 7 [educational disc]. Edited by Rose BD. Wellesley, MA: 2000:1–5; also available at: //http.www.uptodate.com.Google Scholar
- 13.Buvat J, Quittelier E, Lemaire A, et al.: Electromyography of the human penis, including single potential analysis during flaccidity and erection induced by vasoactive agents. Int J Impot Res 1990, 2(suppl):85–86.Google Scholar
- 18.AACE clinical practice guidelines for the evaluation and treatment of male sexual dysfunction [no authors listed]. Endocr Pract 1998, 4:219–234.Google Scholar
- 19.Paty BW, Hirsch I: Erectile dysfunction in diabetes. Practical Diabetol 2000, June:16–23.Google Scholar
- 23.Viagra [package insert]. New York: Pfizer Inc.; 1999.Google Scholar
- 24.Cheitlin MD, Hutter AM, Brindis RG, et al.: Use of sildenafil (Viagra) in patients with cardiovascular disease. Circulation 1999, 99:168–177. An expert consensus statement developed by the American College of Cardiology and American Heart Association regarding the use of sildenafil for ED.PubMedGoogle Scholar
- 25.Kloner RA: Sex and patient with cardiovascular risk factors: focus on sildenafil 2000, 109: 13S–21S.Google Scholar
- 28.Labasky RC, Spivack AP: Transurethral alprostadil for treatment of erectile dysfunction: two-year safety update [abstract]. J Urol 1998, 159:907A.Google Scholar
- 29.Trapp JD, Edelman SV: Male impotence is a couple’s problem. In Taking Control of Your Diabetes. Caddo, LA: Professional Communications; 2000:81.Google Scholar
- 30.Levine LA, Dimitiou RJ: Vacuum constriction and external erection devices in erectile dysfunction. Urol Clin North Am 2001, 28:355–361. Examines the development, mechanism of action, efficacy, and patient satisfaction with regard to all vacuum constriction and external erection devices.CrossRefGoogle Scholar